BTS
CLDX icon

BB&T Securities’s Celldex Therapeutics CLDX Stock Holding History

BB&T Securities’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,133
Closed -$9K – 1613
2018
Q4 		$9K Hold
3,133
– – ﹤0.01% 1472
2018
Q3 		$21K Hold
3,133
– – ﹤0.01% 1568
2018
Q2 		$23K Hold
3,133
– – ﹤0.01% 1527
2018
Q1 		$109K Sell
3,133
-4
-0.1% -$155 ﹤0.01% 1456
2017
Q4 		$133K Sell
3,137
-40
-1% -$1.71K ﹤0.01% 1394
2017
Q3 		$136K Hold
3,177
– – ﹤0.01% 1344
2017
Q2 		$117K Buy
+3,177
New +$141K ﹤0.01% 1343

Other funds holding CLDX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return